GH1 and pituitary tumor: Once GH-secreting PitNET is suspected, a multidisciplinary team (MDT) that includes experts specialized in neuroendocrinology, neurosurgery, neuroradiology, radiation oncology, medical oncology, and neuropathology should be involved in the diagnosis, treatment, and follow-up of the patient, ideally in a Pituitary Tumors Centers of Excellence (PTCOEs) in a single institution [48].